Rituximab (MabThera) therapy and safety management. Clinical tool guide.
Pham
Thao
T
Fautrel
Bruno
B
Gottenberg
Jacques-Eric
JE
Goupille
Philippe
P
Hachulla
Eric
E
Masson
Charles
C
Morel
Jacques
J
Mouthon
Luc
L
Saraux
Alain
A
Schaeverbeke
Thierry
T
Wendling
Daniel
D
Mariette
Xavier
X
Sibilia
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D011247:Pregnancy; D011364:Professional Practice; D012219:Rheumatology / Q000379:methods*; D000069283:Rituximab; D017751:Safety Management; D014657:Vasculitis / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab